Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics

Details for Australian Patent Application No. 2010210026 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Speirs, Robert J.; Schaeffler, Barbara A.; Challoner, Peter B.

Agent FB Rice

Pub. Number AU-A-2010210026

Parent 2007202942

Filing date 9 August 2010

Wipo publication date 2 September 2010

International Classifications

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 31/7036 (2006.01)

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

26 August 2010 Complete Application Filed

2 September 2010 Application Open to Public Inspection

  Published as AU-A-2010210026

23 December 2010 Assignment before Grant

  Novartis Vaccines and Diagnostics, Inc. The application has been assigned to Novartis AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210027-Aperture formation for roll formed products

2010210025-Method and apparatus for making aerated food product and product obtainable thereby